| Period | 2019-12-01~2019-12-31 |
|---|---|
| Diagnosis | Gliosarcoma |
| Gender |
|
| Age | 55 |
| Clinical information | M/55 2주 전부터 시작된 general weakness, dysphagia, gait disturbance 진단은? |
| Discussion | Gliosarcoma Introduction Both gliomatous + sarcomatous components Rare CNS neoplasm (1.8%~2.6%) Peak: 5th-6th decade, slight male preponderance Recent genetic studies suggest a monoclonal origin of gliosarcoma and an evolution of sarcomatous component due to acquisition of a mesenchymal phenotype in a highly malignant astrocytic tumor Worse prognosis than GBM Treatment - Adjuvant therapy (radiotherapy, chemotherapy) is recommended Recurrence common Imaging findings of Gliosarcoma In temporal (44%) and parietal (28%) lobes Peripheral tumor location with dural involvement Gliosarcoma with meningioma like appearance Well circumscribed, homogenous enhancement High sarcomatous component High propensity to metastasize Worse prognosis Gliosarcoma with GBM like appearance Heterogeneous, ill-defined lesion with patchy/ring enhancement |
| Correct answer |
Correct AnswerSemi-Correct Answer |